Skip to main content

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Diabetes Prevention Program Outcomes Study (DPPOS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Altshuler, Rachel, Ph.D. rachel.altshuler@nih.gov 240-276-5873	5E304	Program Officer \| Breast and Gynecologic Cancer
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	Brofsky, Emma, M.S.P.H. emma.brofsky@nih.gov 240-276-7532	5E314	Program Analyst \| Breast and Gynecologic Cancer
	Dimond, Eileen, R.N., M.S. eileen.dimond@nih.gov 240-276-7086	5E332	Nurse Consultant \| Breast and Gynecologic Cancer
	Frech, Maria Silvina, Ph.D., M.S. maria.frech@nih.gov 240-276-5302	5E320	Program Officer \| Breast and Gynecologic Cancer
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Perloff, Marjorie, M.D. marjorie.perloff@nih.gov 240-276-7097	5E544	Program Officer \| Breast and Gynecologic Cancer
	Rubinstein, Wendy, M.D., Ph.D. wendy.rubinstein@nih.gov	5E436	Program Officer \| Breast and Gynecologic Cancer
	Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H. vikrant.sahasrabuddhe@nih.gov 240-276-7332	5E444	Deputy Chief \| Breast and Gynecologic Cancer
	Samimi, Goli, Ph.D., M.P.H. goli.samimi@nih.gov 240-276-6582	5E336	Program Officer \| Breast and Gynecologic Cancer
	Sauter, Edward, M.D., Ph.D. edward.sauter@nih.gov 240-276-7657	5E338	Program Officer \| Breast and Gynecologic Cancer
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Wood (Gunn), Kristen, B.S.N. kristen.gunn@nih.gov	5E326	Nurse Consultant \| Breast and Gynecologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Cantuaria, Guilherme	Northside Hospital Atlanta United States	Georgia NCI Community Oncology Research Program (GA NCORP)	3UG1CA189997-11S1	Vanessa A. White, M.P.H.
Cao, Yin	Washington University United States	PROSPECT-Global Consortium and Risk Factor Discovery	3OT2CA297576-01S1	Asad Umar, D.V.M., Ph.D.
Cao, Shugeng	University Of Hawaii At Hilo United States	Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors	5UG3CA290375-02	Altaf Mohammed, Ph.D.
Cao, Yin	Washington University United States	Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia	4R37CA246175-06	Asad Umar, D.V.M., Ph.D.
Cao, Weidan	Ohio State University United States	Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System	1R01CA301579-01	Eileen Dimond, R.N., M.S.
Carlson, Jay W	Ozark Health Ventures, Llc United States	Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)	3UG1CA189822-11S1	Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun	H. Lee Moffitt Cancer Ctr & Res Inst United States	Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults	5R01CA253219-06	Young Kim, Ph.D.
Castilla, Lucio H.	Univ Of Massachusetts Med Sch Worcester United States	Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD	1U01CA296350-01	Marjorie Perloff, M.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	3U01CA279858-03S2	Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-04
Caywood, Emi H	Nemours Children'S Hospital, Delaware United States	Nemours NCI Community Oncology Research Program (NCORP)	3UG1CA189958-11S1	Vanessa A. White, M.P.H.
Chak, Amitabh	Case Western Reserve University United States	Pathways of Injury and Repair in Barrett's Carcinogenesis	5P01CA269019-03	Asad Umar, D.V.M., Ph.D.
Chan, Alexandre	University Of California-Irvine United States	Neurotrophic strategy to mitigate chemotherapy-related brain injury	5R01CA276212-03	John Clifford, Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297680-01S1	Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-03	Matthew Young, Ph.D.